Literature DB >> 6369673

Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft.

F A Zimmermann, H S Davies, P P Knoll, J M Gokel, T Schmidt.   

Abstract

This report describes the fate of orthotopic liver allografts performed in 22 donor/recipient strain combinations. Of these, 2 were major histocompatibility complex (MHC)-congenic, 18 were fully allogeneic, and 2 were non-RT1 incompatible combinations considered to differ only in minor transplantation antigens. The fate of fully allogeneic liver grafts was strictly dependent on the donor/recipient strain combination, and survival times fell into three nonoverlapping groups corresponding to acute rejection (8-21 days), delayed rejection (28-63 days), and prolonged survival (greater than 100 days). Serial levels of recipient serum enzymes also fell into groups corresponding to the fate of the graft. In 7 fully allogeneic donor/recipient combinations, liver grafts showed very prolonged survival. In five combinations they were rejected almost as quickly as kidney or heart grafts. In the two MHC congenic combinations, liver grafts survived for prolonged periods. In the non-RT1-incompatible combinations, unexpectedly, PVG livers were rejected by AUG recipients. MHC-incompatible liver grafts of a given strain survived for long periods or were rejected (in acute or delayed fashion) depending on the recipient strain. This behavior is unique to liver amongst commonly transplanted vascularized organs, and the fate of the graft clearly indicates strain-dependent levels of recipient responsiveness to defined transplantation antigens. Independent evidence supporting this conclusion is discussed. Apparently anomalous results of liver grafting in certain strain combinations are briefly considered.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369673     DOI: 10.1097/00007890-198404000-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

1.  The birth of clinical organ transplantation.

Authors:  T E Starzl
Journal:  J Am Coll Surg       Date:  2001-04       Impact factor: 6.113

Review 2.  The "privileged" liver and hepatic tolerogenicity.

Authors:  T E Starzl
Journal:  Liver Transpl       Date:  2001-10       Impact factor: 5.799

3.  The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967).

Authors:  Thomas E Starzl
Journal:  J Am Coll Surg       Date:  2002-11       Impact factor: 6.113

4.  History of clinical transplantation.

Authors:  T E Starzl
Journal:  World J Surg       Date:  2000-07       Impact factor: 3.352

5.  Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation.

Authors:  Tai-Long Pan; Pei-Wen Wang; Chao-Chen Huang; Shigeru Goto; Chao-Long Chen
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

6.  Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.

Authors:  Yan Li; Lina Lu; Shiguang Qian; John J Fung; Feng Lin
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

Review 7.  The unfinished legacy of liver transplantation: emphasis on immunology.

Authors:  Thomas E Starzl; Fadi G Lakkis
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 8.  [Immunologic tolerance after experimental liver transplantation].

Authors:  M Knoop; U Neumann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

9.  Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection.

Authors:  Timi Martelius; Ville Salaspuro; Marko Salmi; Leena Krogerus; Krister Höckerstedt; Sirpa Jalkanen; Irmeli Lautenschlager
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation.

Authors:  K L Rokahr; A F Sharland; J Sun; C Wang; A G Sheil; Y Yan; G W McCaughan; G A Bishop
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.